Methyl cap binding protein 2: a key epigenetic protein in systemic sclerosis

Henderson, John, Brown, Max, Horsburgh, Steven, Duffy, Laura, Wilkinson, Sarah, Worrell, Julie, Stratton, Richard and O'Reilly, Steven (2019) Methyl cap binding protein 2: a key epigenetic protein in systemic sclerosis. Rheumatology, 58 (3). pp. 527-535. ISSN 1462-0324

Full text not available from this repository. (Request a copy)
Official URL: https://doi.org/10.1093/rheumatology/key327

Abstract

Objective SSc is an autoimmune connective tissue disease that results in skin fibrosis and currently has no effective treatment. Epigenetic modifications have been described and these may be key in initiating and driving fibroblast activation. Among these epigenetic modifications methylation may be of central importance. The aim of this study was to examine the role of methyl cap binding protein-2 (MeCP2) in SSc fibrosis. Methods We used healthy and SSc dermal fibroblasts to examine the role of MeCP2, using both small interfering RNA silencing and lentiviral overexpression to determine its effects. We also examined the expression of MeCP2 in SSc fibroblasts by immunoblotting. miRNA132 was quantified by Taqman real time PCR. Results We demonstrated that TGF-β1 induced the expression of MeCP2 in normal cells, and showed that SSc fibroblasts expressed high levels of MeCP2 under basal conditions. MeCP2 positively regulated the expression of extracellular matrix through epigenetic repression of the Wnt antagonist sFRP-1, leading to enhanced Wnt signalling. This mediated fibrosis through glycolysis, as the glycolysis inhibitor 2-deoxyglucose diminished the Wnt-mediated collagen expression. MiR132 expression was reduced in SSc fibroblasts. Conclusion The results suggest that an epigenetic loop exists mediating fibrosis. Targeting of MeCP2, as a key epigenetic regulator, may be a promising therapeutic approach, as would targeting the metabolic reprogramming that occurs through aerobic glycolysis.

Item Type: Article
Uncontrolled Keywords: systemic sclerosis, epigenetics, fibrosis, methylation, Wnt
Subjects: B200 Pharmacology, Toxicology and Pharmacy
Department: Faculties > Health and Life Sciences > Applied Sciences
Depositing User: Elena Carlaw
Date Deposited: 14 Mar 2019 15:57
Last Modified: 17 Sep 2019 08:04
URI: http://nrl.northumbria.ac.uk/id/eprint/38406

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics


Policies: NRL Policies | NRL University Deposit Policy | NRL Deposit Licence